ArticleBMC cancer2021

Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations.

Yi-Chieh Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.